77.65
0.10 (0.13%)
0.10 (0.13%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Merck and Co Inc | MRK | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.29 | 0.38% | 77.55 | 76.00 | 77.64 | 77.08 | 77.26 | 20:00:00 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 87,978 | 12,245,127 | $ 76.98 | $ 942,593,472 | 10,555,132 | 65.25 - 92.64 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:18 | 18 | $ 77.65 | USD |
Merck Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 195.74B | 2.52B | 2.52B | $ 46.84B | $ 9.87B | 3.81 | 19.40 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 18.89M | $ 2.26 | 2.91% | - | - |
Merck News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRK Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 78.03 | 81.00 | 76.00 | 76.96 | 10,852,165 | -0.48 | -0.62% |
| 1 Month | 82.19 | 82.46 | 75.40 | 77.88 | 10,310,719 | -4.64 | -5.65% |
| 3 Months | 81.55 | 84.75 | 65.25 | 76.97 | 13,486,122 | -4.00 | -4.9% |
| 6 Months | 87.36 | 92.64 | 65.25 | 80.98 | 11,729,503 | -9.81 | -11.23% |
| 1 Year | 81.38 | 92.64 | 65.25 | 82.18 | 10,407,427 | -3.83 | -4.71% |
| 3 Years | 64.72 | 92.64 | 52.83 | 71.75 | 10,163,501 | 12.83 | 19.82% |
| 5 Years | 59.09 | 92.64 | 45.69 | 66.42 | 9,787,075 | 18.46 | 31.24% |
Merck Description
| Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiovascular disease, asthma, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to 40% of the firm's sales are generated in the United States. |
